Shaw Christine 4
4 · GenMark Diagnostics, Inc. · Filed Sep 10, 2020
Insider Transaction Report
Form 4
Shaw Christine
VP, Assay Development
Transactions
- Sale
Common Stock
2020-09-08$11.02/sh−285$3,141→ 79,714 total
Footnotes (1)
- [F1]The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted restricted stock units.